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1. Introduction  
IgM nephropathy (IgMN) is a relatively recently described, and still a controversial clinico-
immunopathologic entity which presents mainly as idiopathic nephrotic syndrome (INS) in 
both children and adults (Al-Eisa et al., 1996). The disease, like IgA nephropathy (IgAN), is 
defined by its immunohistologic features: the presence of immunoglobulin M (IgM) as the 
sole or dominant immunoglobulin in the mesangium of the glomeruli in a diffuse (all 
glomeruli) and global (whole glomerulus) distribution (Bhasin et al., 1978; Cohen et al., 
1978). Similar to IgAN, the light microscopic (LM) features on renal biopsy are very 
heterogeneous, ranging from minimal change lesion to variable degree of mesangial 
proliferation to focal segmental glomerulosclerosis (FSGS) (Mubarak et al., 2010). Electron-
dense deposits in the mesangium are a variable ultrastructural feature. Its epidemiology is 
interesting; the disease is reported mostly from South East Asia and Eastern Europe, but 
sparse studies have also appeared from USA, Canada, and parts of Western Europe. Its 
etiology and pathogenesis are still not well understood (Myllimaki et al., 2003). Owing 
chiefly to controversy over its distinct nature, it has attracted little interest in the scientific 
community. There are very few studies on the prognostic factors (Jungthirapanich et al., 
1997; Myllimaki et al., 2003). Currently, IgMN is treated along the similar lines as minimal 
change disease (MCD) or FSGS, but the response to steroids is less favorable than that of 
MCD. Its prognosis is relatively guarded as compared with MCD. Upto one third of 
individuals with IgMN develop renal insufficiency or one fourth, the end-stage renal disease 
(ESRD) over 15 years of follow-up (Myllimaki et al., 2003). In this chapter, we briefly discuss 
the historical background, etiology, pathogenesis, pathology, clinical manifestations, 
treatment, and prognosis of this relatively young and still largely controversial primary 
glomerulopathy. Further long term longitudinal studies are needed to clarify the status of 
the disease among the primary glomerulopathies.  
2. Historical background 
Although, it is widely believed that this lesion was described for the first time in 1978 by 
two independent research groups led by Cohen (1978), and Bhasin (1978) in patients 
presenting with heavy proteinuria, the deposits of predominant IgM in the glomeruli, in 
fact, were first described in renal biopsies in 1974 by Putte et al. (1974) in patients presenting 
with persistent or recurrent hematuria. Soon after the formal recognition of the disease as a 
distinct entity in 1978, many series were reported on the disease mostly from USA, UK, 
other countries of Europe, and South East Asia (Al-Eisa et al., 1996; Cavalo & Johnson, 1981; 
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Kobayashi et al., 1982; Hamed 2003; Helin et al., 1982; Hsu et al., 1984; Jungthirapanich et al., 
1997; Lawler et al., 1980; Mampaso et al., 1981; Myllimaki et al., 2003; Pardo et al., 1984; Saha 
et al., 1989). Among these, the large series of patients with this disease from Finland are of 
note (Helin et al., 1982; Myllimaki et al., 2003; Saha et al., 1989). However, the interest in the 
disease soon faded, and many investigators, especially in the western world, were reluctant 
to accept the disease as a distinct clinicopathologic entity. The disease is however still being 
reported from different parts of the world (Mubarak et al., 2011).  
3. Epidemiology 
Few studies have been reported on the population based incidence and prevalence, mode of 
presentation, immunopathologic features, pattern of steroid response and the long term 
prognosis of IgMN in either children or adults (Myllymaki et al., 1993). Most of the studies 
have reported the prevalence of the disease as frequency or percentage of renal biopsies with a 
diagnosis of IgMN. The frequency of IgMN reported in literature has varied considerably from 
2% to 18.5% (Al-Eisa et al., 1996; Cavalo et al., 1981; Kazi et al., 2010; Kopolovic et al., 1987; 
Lawler et al., 1980; Mampaso et al., 1981; Cavalo & Johnson, 1981; Chan et al., 2000; Donia et 
al., 2000; Hsu et al., 1984; Jungthirapanich et al., 1997; Kobayashi et al., 1982; Mubarak et al., 
2011; Singhai et al., 2011; Tejani & Nicastri, 1983). The first two pioneering studies found 
frequencies of 2 and 6.1% respectively in their biopsy series (Cohen et al., 1978; Bhasin et al., 
1978). Soon thereafter, a frequency of 11.7% of IgMN was reported in a study by Lawler et al. 
from UK (1980). Hsu et al. (1984) found a frequency of 10% of IgMN in all biopsies with 
primary glomerular disease. One of the largest and long-term longitudinal series on IgMN has 
come from Finland, comprising of 110 patients, including both adults and children (Myllimaki 
et al., 2003). More recently, we have published our experience in the largest study ever carried 
out on 135 children with INS and IgMN as the biopsy diagnosis (Mubarak et al., 2011). The 
exact cause for this wide variation in the prevalence of IgMN is unclear but may be partly due 
to varying biopsy indications, varying criteria for the diagnosis of this lesion used in different 
studies, and partly to genetic or environmental factors. Most of the studies have been 
undertaken on native renal biopsies; however, occasional cases of its occurrence in renal 
transplant recipients have also been reported (Salmon AH et al., 2004).  
4. Etiology 
As with IgAN, the etiology of this common form of primary GN is still largely unknown. 
IgM deposits in the glomeruli may be seen in a variety of systemic diseases, such as 
systemic lupus erythematosus (SLE), rheumatoid arthritis, diabetes mellitus, Alport’s 
syndrome, and paraproteinemia. For a diagnosis of primary IgMN, the above conditions 
must be excluded.   
5. Pathogenesis 
As with the etiology, the pathogenesis of this disease is also still elusive. Very few studies 
have been undertaken on the pathogenesis of this condition, mainly because this disease is 
not accepted widely as a distinct entity in most of the western countries (Border, 1988). 
Some investigators have suggested classical immune complex mediated activation of 
complement system leading to mesangial injury and reaction (Hsu et al., 1984). They cite as 
evidence the presence of C1q and C4 deposits along with IgM in glomerular mesangium in 
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majority of cases, while properdin and factor B were not found (Hsu et al., 1984). Others 
have found C3 in majority of cases and C1q only infrequently (Mubarak et al., 2011). The 
source of antigens triggering immune complex formation is not known, but it is 
hypothesized that certain antigens in the food or environment which preferentially elicit 
IgM response may be responsible. Abnormalities of T-lymphocyte function or a disturbance 
in immune complex clearance by mesangial cells have also been suggested (Hsu et al., 1984). 
Many studies have found increased serum IgM or IgM immune complex concentrations in 
patients with IgMN (Disciullo et al., 1988; Hsu et al., 1984). No abnormalities of IgM 
molecule, as are observed in IgA, have been detected or reported as yet. Similarly, no animal 
studies have been conducted on this disease till now.  
6. Pathology 
The diagnosis of IgMN requires, like IgAN, examination of renal biopsy by at least LM and 
IF methods. EM is not essential but optional and often confirms the findings seen on LM and 
IF. The pathologic findings are correlated with clinical and serological studies to diagnose 
the primary form of the disease.  
6.1 Light microscopy 
The LM findings in IgMN are heterogeneous, as in IgAN. The spectrum of changes is 
however not as wide as in IgAN and includes minor changes, variable degree of mesangial 
proliferation, usually of mild to moderate degree, and FSGS (Mubarak et al., 2011; 
Myllimaki et al., 2003) (Fig. 1, 2). Many biopsies also display small cellular crescents (Lawler 
et al., 1980; Kishimoto & Arakawa, 1999). The most common morphologic change reported 
consists of mesangial proliferation of the glomeruli, mostly of mild to moderate degree (Hsu 
et al., 1984). In a minority of cases, severe mesangial proliferation with interpositioning of 
the expanded mesangium into the peripheral capillary walls with consequent splitting and 
tram-track appearance have also been noted (Kishimoto & Arakawa, 1999). Minor changes 
on LM are reported in about one third of cases (Hsu et al., 1984; Mubarak et al., 2011; 
Myllimaki et al., 2003). FSGS morphology is also commonly reported in IgMN.  These cases 
show diffuse mesangial positivity of IgM in contrast to nonspecific, segmental trapping of 
IgM in idiopathic FSGS. The previously reported prevalence of this morphologic pattern in 
biopsies of IgMN shows wide variation (Lawler et al., 1980; Mubarak et al., 2011; Myllimaki 
et al., 2003). Some investigators have entirely excluded this lesion in their study patients; 
others have included those cases of FSGS showing diffuse mesangial positivity of IgM in the 
category of IgMN, as in our study (Mubarak et al., 2011). The reported rates of this lesion 
have varied from 9 to 65.2% (Mubarak et al., 2011; Myllimaki et al., 2003). This pattern was 
also noted in one third of the cases in our study (Mubarak et al., 2011). Still other 
investigators have reported progression of IgMN cases with minor changes or mesangial 
proliferation into FSGS on repeat biopsies (Myllimaki et al., 2003; Zeis et al., 2001). We have 
observed one case each of florid crescentic GN and a case of collapsing FSGS as a 
morphologic expression of IgMN (unpublished data). Tubular atrophy and interstitial 
scarring are also commonly observed on renal biopsies of IgMN at the time of diagnosis and 
are usually mild (Mubarak et al., 2011; Myllimaki et al., 2003). Moderate and severe tubular 
atrophy have been rarely reported. Mild fibrointimal thickening of arteries has also been 
reported in a minority of cases (Mubarak et al., 2011).  
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Like IgAN, IgMN is a diagnosis of IF microscopy. Characteristic of the disease is a diffuse 
and  global mesangial positivity of IgM (either as sole immunogloblulin or predominant) of 
at least 1+ intensity on a scale of 0-3+ (where 0 is absent, 1+ is mild, 2+ is moderate, and 3+ 
is marked) (Mubarak et al., 2011; Myllimaki et al., 2003) (Fig. 3). Some studies have included 
trace positivity of IgM on IF as IgMN. Concomitant but not dominant deposits of IgA and 
IgG are found in a small percentage of cases (Mubarak et al., 2011; Myllimaki et al., 2003). 
Complement fragments of C3 and C1q are found in majority of cases co-localized with IgM 
deposits (Mubarak et al., 2011; Myllimaki et al., 2003; Zeis et al., 2001).  
6.3 Electron microscopy 
There are very few studies on the ultrastructural features of IgMN. In majority of cases, no 
EM was done and the diagnosis was made solely on IF microscopy. The few studies that 
have carried out EM examination have noted small, granular to short linear, electron-dense 
deposits in the mesangium and paramesangium, along with variable degrees of mesangial 
cell proliferation and mesangial matrix expansion. Variable degrees of fusion of foot 
processes commensurate with the degree of proteinuria have also been observed. The 
electron-dense deposits have typically been of low volume and low density, and in many 
cases, rather ill-defined (Al-Eisa et al., 1996; Hsu et al., 1984; Myllimaki et al., 2003).  
 
 
Fig. 1. Medium-power view showing a glomerulus with minor changes on light microscopy. 
There is no significant mesangial proliferation. Capillary lumena are intact. This 
morphological pattern is observed in about one third of cases of IgM nephropathy. (Jone’s 
methenamine silver, ×200). 
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Fig. 2. High-power view showing a glomerulus with mild mesangial cell proliferation and 
moderate mesangial matrix expansion. Peripheral capillary walls are thin. This is the most 
common morphological pattern observed in cases of IgM nephropathy. (PAS, ×400). 
7. Clinical manifestations 
Clinically, the disease most commonly presents with INS in both children and adults. The 
disease also frequently presents with hematuria (HU) or asymptomatic urinary 
abnormalities (AUA). However, in many centers of the world, patients with the later 
manifestations are not subjected to renal biopsy, which accounts for the low number of 
patients presenting with these manifestations. It is believed that patients with HU, especially 
adult females, have a good prognosis, as compared with patients with NS or proteinuria 
(PU) (Myllimaki et al., 2003). Hypertension is frequent at presentation or biopsy, being 
found in roughly one third of cases. Its prevalence increases with increasing duration of the 
disease approaching 50% at 15 years of follow-up (Myllimaki et al., 2003).  
The disease predominantly affects males as compared with females. Some studies have 
found a female preponderance, especially in those patients presenting with HU. Isolated HU 
or proteinuria-hematuria (PU-HU) have constituted almost half of biopsy indications in 
some previous reports (Myllimaki et al., 2003). This may have implications for the severity 
of the pathological lesions observed on renal biopsy and the long term outcome of disease. It 
has been observed, however, that IgMN in children mostly presents as INS rather than as 
HU or PU, as shown in the study by Myllimaki et al. (2003), in which 32 of 36 children with 
IgMN presented as NS and only four children presented with non nephrotic proteinuria and 
none presented with PU-HU or HU. 
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Fig. 3. Medium-power view showing a glomerulus with bright (3+ on a scale of 0 to 3+), 
granular, and global positivity of IgM mainly in the mesangium of the glomerulus on 
immunoflourescence. (Immunoflourescence for IgM, ×200). 
8. Treatment 
IgMN is treated in the same manner as MCD or FSGS. Corticosteroids form the mainstay of 
treatment. Similar to its prevalence, the steroid response pattern in IgMN varies 
considerably; steroid resistance reported varies from 0 to 52% (Border, 1988). We found a 
steroid resistance pattern in about one third of our children presenting with INS. Border 
(1988). also found a mean of 28% steroid resistance on a review of nine published studies of 
IgMN (Border, 1988). It follows from these studies that IgMN responds less well to steroids 
compared to typical minimal change disease (MCD), and favors the hypothesis that IgMN is 
distinct from MCD (Mubarak et al., 2011; Myllimaki et al., 2003). Other researchers have not 
found any significant differences in clinical, pathological or steroid response pattern among 
these diseases (Al-Eisa et al., 1996; Ji-Yun et al., 1984).   
9. Clinical course and prognosis 
The clinical course and prognosis of IgMN are also very variable. Part of the variation in the 
studies is due to variable length of follow-up of the patients and variable case definitions. In 
the largest and longest follow-up study from Finland, renal insufficiency was observed in 
35% of cases at 15 years after biopsy, and ESRD was found in 23% of cases (Myllimaki et al., 
2003). They also looked for clinical and pathological prognostic factors leading to renal 
insufficiency or ESRD. In multivariate analysis, hypertension was the only factor that 
predicted renal insufficiency; on the other hand, none of the multiple factors analyzed was 
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predictive of ESRD. They proposed that this may be due to small number of patients 
reaching ESRD in their study (Myllimaki et al., 2003). Another study identified microscopic 
HU, extent of mesangial proliferation, and global glomerulosclerosis as independent 
prognostic markers on multivariate analysis (O’Donoghue et al., 1991). 
One important complication of IgMN is the transition of the usual mesangial proliferative 
lesion into the morphologic expression of FSGS. The later is diagnosed only in re-biopsies 
(Myllimaki et al., 2003; Zeis et al., 2001).  
10. Conclusion 
In conclusion, IgMN is an important cause of renal morbidity in both children and adults in 
many parts of the world. It shows a spectrum of morphologic changes ranging from minor 
changes to FSGS. Immunoflourescence is necessary for its diagnosis. Clinically, a poor 
response to steroid therapy distinguishes this disease from MCD. Further long term 
longitudinal studies are needed to clarify the status of the disease among the primary  
glomerulopathies. More studies are also needed to elucidate the etiology and pathogenesis 
of this disease and develop effective therapeutic regimens.  
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